BioCentury
ARTICLE | Company News

Celltech Group, Thiemann GmbH deal

September 17, 2001 7:00 AM UTC

CCH will purchase Thiemann and its Thiemann Arzneimittel pharmaceutical sales and marketing subsidiary for £31 million ($45.26 million) in cash. Thiemann markets products for cardiology, rheumatism, C...